
Innotaxel 300mg Injection
Marketer
Innova Formulations Pvt Ltd
Salt Composition
Paclitaxel (300mg)
Overview Innotaxel 300mg Injection
Taxotere 300mg Injection, an anticancer agent, treats breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, and fatigue. Serious side effects like edema (swelling of hands/face), alopecia (hair loss), and weight increase are possible. Your physician may prescribe additional medication to mitigate side effects. Report unusual bruising/bleeding, sore throat, mouth sores, or fever immediately. This medication can decrease blood cell counts, raising infection risk. Regular blood tests monitor blood cell levels and liver function. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent infection treatments. Interaction with other medications is possible; disclose all medications. Use during pregnancy or breastfeeding is contraindicated; effective contraception for both partners is essential throughout treatment.
Uses of Innotaxel 300mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Innotaxel 300mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Innotaxel 300mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Innotaxel 300mg Injection:
Administering this medication will be handled by your physician or their qualified assistant; self-medication is strictly prohibited.
How Innotaxel 300mg Injection works:
Taxotere 300mg Injection, a chemotherapy agent, disrupts the microtubules crucial for cancer cell division and proliferation. This action inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Combining Innotaxel 300mg Injection and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering 300mg Innotaxel injections during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might exceptionally prescribe it when the potential advantages outweigh the inherent dangers. Patient consultation with their doctor is essential.
Breast feedingUNSAFE
Breastfeeding mothers should not use Innotaxel 300mg Injection. Evidence indicates potential harm to the infant from this medication.
DrivingUNSAFE
Innotaxel 300mg Injection can induce adverse reactions that might impair driving ability. While there's no inherent prohibition on driving between Innotaxel 300mg Injection treatments, consider that the medication includes alcohol, potentially making driving inadvisable.
KidneySAFE IF PRESCRIBED
Innotaxel 300mg Injection poses no safety concerns for individuals with impaired renal function, and no dosage modification is advised. Nevertheless, patients with pre-existing kidney conditions should consult their physician.
LiverCAUTION
Patients with liver impairment should receive Innotaxel 300mg Injection cautiously, potentially requiring dosage modification. Consult a physician before administration. Innotaxel 300mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Innotaxel 300mg Injection :
NA
Facts to Know About Innotaxel 300mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Taxanes: Antimicrotubule Agents |
